These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 37781472)

  • 1. Anti-GAD antibody-positive fulminant type 1 diabetes developed following SARS-CoV-2 vaccination.
    Izumi T; Takahashi H; Takahashi H
    Diabetol Int; 2023 Oct; 14(4):422-426. PubMed ID: 37781472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New-onset fulminant type 1 diabetes after severe acute respiratory syndrome coronavirus 2 vaccination: A case report.
    Sasaki K; Morioka T; Okada N; Natsuki Y; Kakutani Y; Ochi A; Yamazaki Y; Shoji T; Ohmura T; Emoto M
    J Diabetes Investig; 2022 Jul; 13(7):1286-1289. PubMed ID: 35167186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fulminant Type 1 Diabetes Mellitus after SARS-CoV-2 Vaccination: A Case Report.
    Lin R; Lin YW; Chen MH
    Vaccines (Basel); 2022 Nov; 10(11):. PubMed ID: 36423001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New-Onset Fulminant Type 1 Diabetes Following SARS-CoV-2 Protein Subunit Vaccine: A Case Report and Literature Review.
    Huang L; Liang M; He Y
    J Korean Med Sci; 2023 Jun; 38(24):e209. PubMed ID: 37337812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New-onset Type 1 Diabetes after COVID-19 mRNA Vaccination.
    Yano M; Morioka T; Natsuki Y; Sasaki K; Kakutani Y; Ochi A; Yamazaki Y; Shoji T; Emoto M
    Intern Med; 2022 Apr; 61(8):1197-1200. PubMed ID: 35135929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Case report: Strong GAD antibody positivity and type 1 diabetes-HLA-susceptible haplotype-DRB1*04:05-DQB1*04:01 in a Japanese patient with immune checkpoint inhibitor-induced type 1 diabetes.
    Yabuki S; Hirai H; Moriya C; Kusano Y; Hasegawa T
    Front Endocrinol (Lausanne); 2024; 15():1407192. PubMed ID: 38841300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Case report: Fulminant type 1 diabetes following paucisymptomatic SARS-CoV-2 infection during late pregnancy.
    Zhou L; Qu H; Zhang Q; Hu J; Shou L
    Front Endocrinol (Lausanne); 2023; 14():1168927. PubMed ID: 37082120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New-onset atypical fulminant type 1 diabetes after COVID-19 vaccination: A case report.
    Kobayashi T; Yakou F; Saburi M; Hirose A; Akaoka H; Hirota Y; Yunaiyama D; Asahi N; Ohno A; Matsushita T
    Clin Case Rep; 2022 Oct; 10(10):e6473. PubMed ID: 36267825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sodium-glucose co-transporter-2 inhibitor-associated euglycemic diabetic ketoacidosis that prompted the diagnosis of fulminant type-1 diabetes: A case report.
    Yasuma T; Okano Y; Tanaka S; Nishihama K; Eguchi K; Inoue C; Maki K; Uchida A; Uemura M; Suzuki T; D'Alessandro-Gabazza CN; Gabazza EC; Yano Y
    World J Clin Cases; 2021 May; 9(13):3163-3169. PubMed ID: 33969104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Case of Fulminant Type 1 Diabetes with Transient Production of Anti-Glutamic Acid Decarboxylase Antibody.
    Harada N; Nakayama H; Nomura M
    Am J Case Rep; 2024 May; 25():e943590. PubMed ID: 38751092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Graves' Disease after Administration of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccine in a Type 1 Diabetes Patient.
    Sakai M; Takao K; Kato T; Ito K; Kubota S; Hirose T; Liu Y; Mizuno M; Hirota T; Suwa T; Horikawa Y; Yabe D
    Intern Med; 2022; 61(10):1561-1565. PubMed ID: 35569928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HLA typing of patients who developed subacute thyroiditis and Graves' disease after SARS-CoV-2 vaccination: a case report.
    Yasuda S; Suzuki S; Yanagisawa S; Morita H; Haisa A; Satomura A; Nakajima R; Oikawa Y; Inoue I; Shimada A
    BMC Endocr Disord; 2023 Mar; 23(1):54. PubMed ID: 36879263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Class II HLA genotype in fulminant type 1 diabetes: A nationwide survey with reference to glutamic acid decarboxylase antibodies.
    Tsutsumi C; Imagawa A; Ikegami H; Makino H; Kobayashi T; Hanafusa T;
    J Diabetes Investig; 2012 Feb; 3(1):62-9. PubMed ID: 24843547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Type 1 diabetes mellitus following SARS-CoV-2 mRNA vaccination.
    Aydoğan Bİ; Ünlütürk U; Cesur M
    Endocrine; 2022 Oct; 78(1):42-46. PubMed ID: 35809159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammatory myopathy occurring shortly after severe acute respiratory syndrome coronavirus 2 vaccination: two case reports.
    Vutipongsatorn K; Isaacs A; Farah Z
    J Med Case Rep; 2022 Jan; 16(1):57. PubMed ID: 35094715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fulminant type 1 diabetes mellitus exhibits distinct clinical and autoimmunity features from classical type 1 diabetes mellitus in Chinese.
    Zheng C; Zhou Z; Yang L; Lin J; Huang G; Li X; Zhou W; Wang X; Liu Z
    Diabetes Metab Res Rev; 2011 Jan; 27(1):70-8. PubMed ID: 21218510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Type 1 diabetes recurrence after SARS-CoV-2 infection in a subject with pancreas transplantation.
    Popolla V; Rizzi A; Tartaglione L; Pontecorvi A; Pitocco D
    Endocrinol Diabetes Metab; 2023 Jan; 6(1):e364. PubMed ID: 36307982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fulminant onset of insulin-dependent diabetes with positive anti-GAD antibody titers during treatment with nivolumab in a patient with NSCLC.
    Matsuura N; Koh G; Konishi C; Minamino S; Takahara Y; Harada H; Kodama K; Emoto M
    Cancer Immunol Immunother; 2018 Sep; 67(9):1417-1424. PubMed ID: 29995236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenetic Study of Diabetes Mellitus in Relation to HLA DQ and DR.
    Singh G; Singh U; Singh SK; Singh S
    Indian J Endocrinol Metab; 2020; 24(4):325-332. PubMed ID: 33088755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diabetic ketoacidosis after the second dose of SARS-CoV-2 mRNA vaccination in a patient with pembrolizumab-induced fulminant type 1 diabetes.
    Nishino K; Nakagawa K; Yase E; Terashima M; Murata T
    Diabetol Int; 2023 Apr; 14(2):206-210. PubMed ID: 36575722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.